Clinical trial design is obviously at the basis of the value of the results and the consequent return on investment in terms of image and product support.
Clinical studies, biological samples in general, can generate hundreds of thousands of information which, without good statistical processing, do not lead to a readable result.
The study of complex communities opens very different scenarios: of competition among bacterial populations, effects on the host, inhibition of drug efficacy, interactions with patient's clinical situation.